Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2023-01-13 00:00:00 ET · period of report 2023-01-12 · accession 0001562180-23-000413 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-13 | 2023-01-12+ | SNDX | Legault Pierre | Dir | S - Sale+OE | $26.84 | -39.0K | 32.0K | -55% | -$1.05M |
| DM | 2023-01-13 | 2023-01-12+ | SNDX | Legault Pierre | Dir | M - OptEx | $11.05 | +39.0K | 37.0K | New | +$431.0K |
| DM | 2023-01-13 | 2023-01-12+ | SNDX | Legault Pierre | Dir | M - OptEx | $0.00 | -39.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-13 | S | D | 5,000 | $27.00 | 32,000 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-12 | S | D | 24,000 | $26.74 | 32,000 | D | — | — | (F2) The sale prices ranged from $26.50 to $26.93. |
| 3 | Common | Common Stock | 2023-01-12 | M | A | 24,000 | $9.47 | 56,000 | D | — | — | |
| 4 | Common | Common Stock | 2023-01-13 | M | A | 10,000 | $13.58 | 42,000 | D | — | — | |
| 5 | Common | Common Stock | 2023-01-13 | S | D | 10,000 | $27.00 | 32,000 | D | — | — | |
| 6 | Common | Common Stock | 2023-01-13 | M | A | 5,000 | $13.58 | 37,000 | D | — | — | |
| 7 | Derivative | Stock Options (Right to buy) | 2023-01-13 | M | D | 10,000 | $0.00 | 0 | D | $13.58 · — to 2027-05-17 | 10,000 Common Stock | (F3) This option is fully vested. |
| 8 | Derivative | Stock Options (Right to buy) | 2023-01-13 | M | D | 5,000 | $0.00 | 0 | D | $13.58 · — to 2027-05-17 | 5,000 Common Stock | (F3) This option is fully vested. |
| 9 | Derivative | Stock Options (Right to buy) | 2023-01-12 | M | D | 24,000 | $0.00 | 0 | D | $9.47 · — to 2030-02-12 | 24,000 Common Stock | (F3) This option is fully vested. |